Weave is attending the Stanford Drug Discovery Symposium 2025! This premier event brings together global leaders in biotechnology, pharmaceuticals, and healthcare innovation to explore the latest advancements in drug discovery and development.

Location: Stanford University, California
Dates: April 21–22, 2025

Representing Weave at SDDS 2025:
Brandon Rice, Chief Product Officer (CPO)
Sean Campbell, Chief Operating Officer (COO)

As pioneers in AI-driven regulatory automation, Weave is redefining how biotech and pharma companies streamline IND submissions and maintain compliance. Brandon and Sean will be on-site to discuss how our AI-native Regulatory Automation Management Platform, is transforming regulatory workflows with automated data tagging, submission tracking, and AI-assisted document generation.

Why Connect with Weave at SDDS 2025?

Explore AI in Regulatory Submissions – Learn how automation accelerates the path to approval.
Discuss Industry Challenges – Share insights on regulatory hurdles and solutions.
Network with Our Leadership – Connect with Weave’s experts to explore collaboration opportunities.

If you’re attending SDDS 2025 and want to discuss the future of regulatory automation, let’s connect!

‍